Clearpoint Neuro (CLPT) closed at $9.17 on November 11, 2026, up 4.6% from the previous close, on volume of 426,292 shares (30-day average 685,897).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 6, 2026 | Call Spread | 20-Nov-2610 : 12.5 C | 200 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
Globe Newswire (Tue, 3-Nov 5:48 PM ET)
ClearPoint Neuro Reports Third Quarter 2026 Results
ACCESS Newswire (Wed, 28-Oct 4:05 PM ET)
ClearPoint Neuro Sets Oct. 28 Q3 2026 Results Call, With Replay Available Through Nov. 27
Market Chameleon (Thu, 15-Oct 5:19 AM ET)
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
ACCESS Newswire (Wed, 14-Oct 4:05 PM ET)
Business Wire (Wed, 7-Oct 10:12 PM ET)
ClearPoint Neuro Sets Stage for Growth with Focused Ultrasound Expansion and Regulatory Tailwinds
Market Chameleon (Tue, 4-Aug 3:06 AM ET)
ClearPoint Neuro Sparks Investor Interest with 10-Year Brain Drug Delivery Partnership
Market Chameleon (Thu, 18-Jun 7:46 AM ET)
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
Clearpoint Neuro trades on the NASDAQ stock market under the symbol CLPT.
As of November 11, 2026, CLPT stock price climbed to $9.17 with 426,292 million shares trading.
CLPT has a beta of 3.12, meaning it tends to be more sensitive to market movements. CLPT has a correlation of 0.18 to the broad based SPY ETF.
CLPT has a market cap of $293.94 million. This is considered a Small Cap stock.
Last quarter Clearpoint Neuro reported $12 million in Revenue and -$.24 earnings per share. This fell short of revenue expectation by $-265,000 and exceeded earnings estimates by $.08.
In the last 3 years, CLPT traded as high as $30.10 and as low as $4.45.
The top ETF exchange traded funds that CLPT belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
CLPT has underperformed the market in the last year with a price return of -44.5% while the SPY ETF gained +12.6%. CLPT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -37.1% and -5.4%, respectively, while the SPY returned -1.5% and -1.3%, respectively.
CLPT support price is $8.32 and resistance is $9.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLPT shares will trade within this expected range on the day.
